![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40620-022-01399-6/MediaObjects/40620_2022_1399_Fig1_HTML.png)
References
Amer H, Fidler ME, Myslak M et al (2007) Proteinuria after kidney transplantation, relationship to allograft histology and survival. Am J Transplant 7:2748–2756
Roodnat JI, Mulder PG, Rischen-Vos J et al (2001) Proteinuria after renal transplantation affects not only graft survival but also patient survival. Transplantation 72:438–444
Fernandez-Fresnedo G, Escallada R, Rodrigo E et al (2002) The risk of cardiovascular disease associated with proteinuria in renal transplant patients. Transplantation 73:1345–1348
De Nicola L, Conte G, Russo D et al (2012) Antiproteinuric effect of add-on paricalcitol in CKD patients under maximal tolerated inhibition of renin-angiotensin system: a prospective observational study. BMC Nephrol 13:150
Gonzalez E, Rojas-Rivera J et al (2013) Effects of oral paricalcitol on secondary hyperparathyroidism and proteinuria of kidney transplant patients. Transplantation 95:e49–e52
Oblak M, Mlinšek G, Kandus A, Buturović-Ponikvar J, Arnol M (2018) Paricalcitol versus placebo for reduction of proteinuria in kidney transplant recipients: a double-blind, randomized controlled trial. Transpl Int 31(12):1391–1404
Funding
No funds were received.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None of the authors had any conflicts of interest.
Ethical approval
The generally accepted principles of ethical and professional conduct have been followed during this study.
Informed consent
All the participants gave their informed consent to the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Garofalo, C., Secondulfo, C., Apicella, L. et al. Antiproteinuric effect of paricalcitol in kidney transplant recipients with severe proteinuria: a prospective cohort study. J Nephrol 35, 1943–1945 (2022). https://doi.org/10.1007/s40620-022-01399-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40620-022-01399-6